471937-78-7 Usage
General Description
3-(Trifluoromethoxy)phenylisothiocyanate is a chemical compound with the molecular formula C8H4F3NOS. It is a colorless, clear liquid that is insoluble in water but soluble in organic solvents. 3-(Trifluoromethoxy)phenylisothiocyanate is primarily used as an intermediate in the production of pharmaceuticals and agrochemicals. It is also used in the synthesis of a variety of organic compounds, including those with potential pharmacological and biological activity. 3-(Trifluoromethoxy)phenylisothiocyanate is known to be a potent and selective inhibitor of certain biological processes and has potential applications in drug development and molecular research. However, it should be handled with care due to its toxic and irritant properties.
Check Digit Verification of cas no
The CAS Registry Mumber 471937-78-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,1,9,3 and 7 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 471937-78:
(8*4)+(7*7)+(6*1)+(5*9)+(4*3)+(3*7)+(2*7)+(1*8)=187
187 % 10 = 7
So 471937-78-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H4F3NOS/c9-8(10,11)13-7-3-1-2-6(4-7)12-5-14/h1-4H
471937-78-7Relevant articles and documents
4-PHENYL-N-(PHENYL)THIAZOL-2-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS
-
Paragraph 00221; 00305, (2021/06/26)
4-phenyl-N-(phenyl)thiazol-2-amine and 4-(pyridin-3-yl)-N-( phenyl) thiazol-2-amine derivatives and the corresponding thiadiazole, thiophene, oxazole, oxadiazole, imidazole and triazole derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of angiogenesis implicated disorders, such as e.g. retinopathy, psoriasis, rheumatoid arthritis, obesity and cancer, or inflammatory disorders.
CYCLIC GUANIDINES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE
-
Page/Page column 66-67, (2010/02/12)
The present invention relates to cyclic guanidines, compositions containing such compounds and methods of treatment. The compounds are glucagon receptor antagonists and thus are useful for treating, preventing or delaying the onset of type 2 diabetes mellitus.
